CORE-006: BEHAVORIAL MEASUREMENT SHARED RESOURCE (BMSR) PROJECT SUMMARY / ABSTRACT The Behavioral Measurement Shared Resource (BMSR) provides expert assistance and services for integrating behavioral and epidemiological research into the research goals of the OSUCCC. The BMSR maintained a high level of usage over the last grant period and provided, or is currently providing, key support for several increasingly large NCI-funded projects and OSUCCC initiatives. It is directed by Dr. Paul Reiter (CC) and the Senior Faculty Advisor is Dr. Michael Slater (CC). The BMSR offers services in five primary areas: 1) research design; 2) behavioral and survey assessment; 3) participant recruitment, accrual and retention; 4) data collection (both quantitative and qualitative data); and 5) population-based data retrieval. Thus, the BMSR provides a continuum of services for research projects, ranging from planning and development of research proposals and projects through data collection and the interpretation of research data.
The Specific Aims are to: 1) provide expertise in research design and behavioral and survey assessment; 2) assist investigators with participant recruitment, accrual and retention to ensure the inclusion of research participants that are broadly representative of the target population(s); and, 3) provide expertise and services for the collection and management of both quantitative and qualitative research data. The BMSR supports increasingly complex studies including population-based cohort studies, universal consenting for all OSUCCC patients into the Total Cancer Care protocol for biobanking, and the statewide colorectal cancer initiative accruing cancer patients and their families across the state of Ohio. Over the last five years, the BMSR supported investigators from all 5 research programs an, contributed to 58 publications and provided services to over 10 NCI funded grants, including 2 NCI P50 Centers. Future plans for the BMSR are to offer support with call management software; ecological momentary assessment (EMA); gain expertise in additional online data collection software programs including mobile applications; and, offering the use of geographic information systems (GIS) software. The BMSR leverages extensive institutional support and seeks only 9.5% support from CCSG funds. The Behavioral Measurement Shared Resource is part of the Quantitative Grouping.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016058-40
Application #
9000505
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2015-12-01
Budget End
2016-11-30
Support Year
40
Fiscal Year
2016
Total Cost
$67,601
Indirect Cost
$23,704
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Lehmann, Vicky; Nahata, Leena; Ferrante, Amanda C et al. (2018) Fertility-Related Perceptions and Impact on Romantic Relationships Among Adult Survivors of Childhood Cancer. J Adolesc Young Adult Oncol 7:409-414
Dix, David B; Seibel, Nita L; Chi, Yueh-Yun et al. (2018) Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study. J Clin Oncol 36:1564-1570
Kohnken, Rebecca; Wen, Jing; Mundy-Bosse, Bethany et al. (2018) Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma. Blood 131:771-781
Londhe, Priya; Yu, Peter Y; Ijiri, Yuichi et al. (2018) Classical NF-?B Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2. Front Oncol 8:104
Valenciaga, Anisley; Saji, Motoyasu; Yu, Lianbo et al. (2018) Transcriptional targeting of oncogene addiction in medullary thyroid cancer. JCI Insight 3:
Kiss, Daniel L; Baez, William D; Huebner, Kay et al. (2018) Loss of fragile histidine triad (Fhit) protein expression alters the translation of cancer-associated mRNAs. BMC Res Notes 11:178
Vasu, Sumithira; Kohlschmidt, Jessica; Mrózek, Krzysztof et al. (2018) Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission. Blood Adv 2:1645-1650
Denton, Nicholas L; Chen, Chun-Yu; Hutzen, Brian et al. (2018) Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment. Mol Ther Oncolytics 11:62-74
Krasnick, Bradley A; Jin, Linda X; Davidson 4th, Jesse T et al. (2018) Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium. J Surg Oncol 117:363-371
Badawi, Mohamed; Kim, Jihye; Dauki, Anees et al. (2018) CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128. Oncotarget 9:26032-26045

Showing the most recent 10 out of 2602 publications